Table 3.
Outcome
Measure |
Baselinea mean ± SD n=18 |
8-Week
mean ± SD n=18 |
3-Month
mean ± SD n=18 |
P-Value
Baseline to 8-Weeks |
P-Value
Baseline to 3-Months |
---|---|---|---|---|---|
Pain | |||||
McGill Pain
Questionnaire- Short Formb |
15.7 ± 9.1 | 12.4 ± 8.5 | 11.4 ± 6.5 | 0.098 | 0.03 |
SF-36
Pain Scale |
38.8 ± 8.3 | 41.0 ± 10.0 | 39.5 ± 8.4 | 0.16 | 0.66 |
Physical Function | |||||
Roland
Disability Questionnaireb |
10.6 ± 5.3 | 8.8 ± 6.5 | 9.4 ± 5.5 | 0.17 | 0.35 |
SF-36
Physical Function Scale |
44.5 ± 10.1 | 45.8 ± 9.3 | 46.8 ± 10.7 | 0.38 | 0.11 |
Pain Acceptance | |||||
Chronic Pain
Acceptance Questionnaire Total Score |
64.8 ± 23.0 | 69.3 ± 20.9 | 68.0 ± 16.8 | 0.07 | 0.19 |
Chronic Pain
Acceptance Questionnaire Activities Engagement |
43.4 ± 13.5 | 47.2 ± 14.2 | 42.7 ± 11.5 | .057 | 0.71 |
Quality of Life | |||||
SF-36
Physical Health Composite |
42.9 ± 9.0 | 44.7 ± 9.5 | 43.9 ± 9.0 | 0.21 | 0.50 |
SF-36
Global Health Composite |
42.9 ± 10.7 | 45.3 ± 10.9 | 42.2 ± 9.6 | 0.17 | 0.67 |
SF-36
Mental Health Composite |
43.2 ± 12.4 | 45.4 ± 12.1 | 41.5 ± 10.7 | 0.30 | 0.42 |
The most proximal pre-treatment data was used as the control group’s baseline.
Lower scores indicate improvement.